Why is Onyx Biotec falling/rising?

As of 23-Sep, Onyx Biotec Ltd is currently priced at 45.80, with no change in price, reflecting a 0.00% movement. The stock has underperformed in the short term, with a 1-week decline of 6.53% and a 1-month decline of 5.76%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Investor participation has also decreased significantly, with a delivery volume drop of 87.95% compared to the 5-day average, suggesting reduced interest in the stock. There is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, Onyx Biotec's performance contrasts sharply with the Sensex, which has seen a slight decline of only 0.28% over the past week and a gain of 1.20% over the past month. Year-to-date, Onyx Biotec has experienced a substantial decline of 23.03%, while the Sensex has increased by 6.45%. This significant underperformance relative to the benchmark indicates that the stock is struggling in the current market environment, further contributing to its price stagnation.